Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 4 Feb 21 424B5 Prospectus supplement for primary offering
- 2 Feb 21 424B5 Prospectus supplement for primary offering
- 2 Feb 21 424B5 Prospectus supplement for primary offering
- 2 Feb 21 424B5 Prospectus supplement for primary offering
- 12 Nov 20 424B5 Prospectus supplement for primary offering
- 17 Jul 20 424B5 Prospectus supplement for primary offering
- 10 Apr 20 EFFECT Notice of effectiveness
- 23 Mar 20 S-3/A Shelf registration (amended)
-
17 Jan 20 S-3/A Shelf registration (amended)
- 23 Dec 19 S-3 Shelf registration
MBRX similar filings
Filing view
External links
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated February 21, 2019 with respect to the consolidated financial statements of Moleculin Biotech, Inc. included in the Annual Report on Form 10-K for the year ended December 31, 2018, which are incorporated by reference in this Registration Statement. We consent to the incorporation by reference of the aforementioned report in this Registration Statement, and to the use of our name as it appears under the caption "Experts".
/s/GRANT THORNTON LLP
Houston, Texas
January 17, 2020